about
MIFlowCyt: the minimum information about a Flow Cytometry ExperimentSystems vaccinology: a promise for the young and the poorImmune response to vaccine adjuvants during the first year of lifeThe Immune System of HIV-Exposed Uninfected InfantsTransfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected NewbornsLinking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected InfantsEarly infancy microbial and metabolic alterations affect risk of childhood asthmaImplications of Age-Dependent Immune Responses to Enterovirus 71 Infection for Disease Pathogenesis and Vaccine Design.Early-Life Host-Microbiome Interphase: The Key Frontier for Immune DevelopmentMaturation of innate responses to mycobacteria over the first nine months of life.Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.Facilitating the analysis of immunological data with visual analytic techniquesPerinatal Immunization With Vaccine-Grade Listeria monocytogenes Provides Protection Against Murine Th2 Airway InflammationFlow cytometry data standards.Identification of B cells through negative gating-An example of the MIFlowCyt standard applied.Correlation analysis of intracellular and secreted cytokines via the generalized integrated mean fluorescence intensity.Altered innate immune development in HIV-exposed uninfected infants.Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents.The role of environmental factors in modulating immune responses in early lifeProfound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis.Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life.Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges.Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella entericaVariables to be controlled in the assessment of blood innate immune responses to Toll-like receptor stimulation.Ponseti clubfoot management: Experience with the Steenbeek foot abduction brace.Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.Age-Related Gene Expression Differences in Monocytes from Human Neonates, Young Adults, and Older Adults.Neonatal innate TLR-mediated responses are distinct from those of adults.An eight-month-old child with cervical adenitis.Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life.Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.Polychromatic flow cytometric high-throughput assay to analyze the innate immune response to Toll-like receptor stimulation.Listeria monocytogenes: a promising vehicle for neonatal vaccination.Vaccine-induced immunity in early life.Induction of antigen-specific immunity in human neonates and infants.
P50
Q24644748-BBC7707C-42AB-4595-AC99-EFD67909A941Q26862121-72E62451-7FB7-47F6-8B0F-B953826E562CQ27016633-C40E3D84-593D-4DE0-9D34-E3A9ECC91E82Q28069872-B1E7664A-58E4-4ADD-959D-C8A5E09E1A6BQ28070259-85289302-8EB5-4640-82A2-35DBB9EC4F4BQ28077904-A5C77502-06EB-409B-B2A3-CE426B27CCF7Q30066441-59240C08-FB0F-4D56-A228-6B2F78439B6BQ30382068-36D947DD-5697-4E2B-9A80-FD751E9E18F3Q33720577-E7A340DD-052B-45FF-8030-4E008E74B1C4Q33723428-0484F1D8-95BE-47D1-B03F-4297B8C29423Q33770015-28BFBB2F-4EE1-402E-AB39-1CC78E93EF68Q33797604-A74E377C-6751-45CA-BBA1-82CFF7A9C46DQ33831595-65B34471-AADB-4326-8E79-D5EC6E2A0E0BQ33840165-46D35D69-FB89-4027-B0B8-B0FFF6F813A7Q33886075-FDF57D5E-C45D-453F-8314-D3EA88F9118FQ34091604-20EB730B-C772-4A0C-90FD-DA60458ACF88Q34098338-2C682DA0-60BD-4B81-A432-3DD7C0FEFDA0Q34146281-93C4CF92-3B64-4310-96C2-8ACB8D5980E5Q34169396-843B972B-96C0-4F26-960E-0CE6DC75BDBDQ34286789-DFF1793F-1DE9-46F5-8681-4E93F4656C61Q34342056-E4E986D4-71CF-403C-B0E0-CB2586FF2E1CQ34427383-808BEB56-F53A-4AE1-B8F4-5FA3A29EFBFFQ34439339-E503FD85-B717-4985-AE18-6B05CC6A4901Q34446653-7E400FD7-AC15-4DED-91AD-5168C93B85D8Q34634401-7801006A-7CAE-43C7-8F82-D6B47FDF6BAAQ34771015-CEC20C4F-A48D-4928-BF12-1787B650946EQ35137965-9ACCE473-B4CB-4E30-BD77-72AAC6AC76F4Q35669044-F3DEFA03-5713-48CD-A859-54F430885C81Q35683728-261D3156-875C-45AE-84A2-A24454C5E93EQ36015806-57461192-37D0-4154-984F-F0885EEC72CDQ36333588-54306566-31C8-4B23-8194-21F286DF2D79Q36362732-69AE085E-FBA2-4967-B908-96826B0CD3A6Q36504806-CE79B84E-871C-4298-96E9-2B1678A75BB2Q36511529-78826A03-B53E-4715-AF07-4E4F02155F2CQ36727938-8101F497-4DCB-4BF2-9573-3DA6867F1769Q36733384-57993CA6-4142-4AF1-B2C4-BC2368C04D0EQ36944446-479022F8-00EA-4685-8D75-BD2E929ABA4FQ36977730-94F0E63C-348F-460B-9154-2754791D483CQ37041021-0A8F802E-0B27-4E6E-9C3A-4CAB0326F98FQ37057548-E432B275-8839-438C-B038-E41DF611E85B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tobias Kollmann
@ast
Tobias Kollmann
@en
Tobias Kollmann
@es
Tobias Kollmann
@nl
Tobias Kollmann
@sl
type
label
Tobias Kollmann
@ast
Tobias Kollmann
@en
Tobias Kollmann
@es
Tobias Kollmann
@nl
Tobias Kollmann
@sl
prefLabel
Tobias Kollmann
@ast
Tobias Kollmann
@en
Tobias Kollmann
@es
Tobias Kollmann
@nl
Tobias Kollmann
@sl
P106
P21
P31
P496
0000-0003-2403-9762
P569
2000-01-01T00:00:00Z